Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00004041
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Post-approval studies (Phase 4)Study completedNCT00075166
What this trial is testing

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

Who this might be right for
Brain NeoplasmsNeoplasm Metastasis
National Institute of Neurological Disorders and Stroke (NINDS) 130
Early research (Phase 1)Study completedNCT00671710
What this trial is testing

Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

Who this might be right for
Brain Tumors
Advocate Hospital System 26
Testing effectiveness (Phase 2)WithdrawnNCT06676917
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
MedSIR
Testing effectiveness (Phase 2)Study completedNCT00004024
What this trial is testing

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute 60
Early research (Phase 1)Study completedNCT01682746
What this trial is testing

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 5
Not applicableUnknownNCT04090268
What this trial is testing

Precision Exercise in Children With Malignant Hemopathies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more
University of Milano Bicocca 380
Testing effectiveness (Phase 2)Ended earlyNCT00691522
What this trial is testing

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

Who this might be right for
Peritumoral Brain EdemaPRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
PharmaNet 60
Testing effectiveness (Phase 2)Study completedNCT01898130
What this trial is testing

Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 27
Not applicableStudy completedNCT00904553
What this trial is testing

Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases

Who this might be right for
Neoplasm Metastasis
University of Rochester 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053880
What this trial is testing

Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme(GBM)
Accendatech USA Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02661282
What this trial is testing

Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma

Who this might be right for
Cytomegalovirus PositiveGlioblastomaGliosarcoma+3 more
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Study completedNCT00814021
What this trial is testing

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Who this might be right for
Kidney CancerMetastatic Cancer
Institut Claudius Regaud 21
Testing effectiveness (Phase 2)WithdrawnNCT04482933
What this trial is testing

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

Who this might be right for
NeoplasmsHigh Grade GliomaGlioblastoma Multiforme+5 more
Pediatric Brain Tumor Consortium
Not applicableLooking for participantsNCT06092125
What this trial is testing

Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

Who this might be right for
Alzheimer DiseaseParkinson DiseaseEpilepsy+1 more
Xuanwu Hospital, Beijing 2,300
Testing effectiveness (Phase 2)Looking for participantsNCT03510208
What this trial is testing

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

Who this might be right for
Malignant Brain NeoplasmMalignant Glioma
Stanford University 46
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Early research (Phase 1)Study completedNCT01654497
What this trial is testing

Dexanabinol in Patients With Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari, M.D., Ph.D. 26
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Early research (Phase 1)Study completedNCT00006025
What this trial is testing

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page